Key Takeaways ・The weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer.

When I was assigned to write my first story about the blockbuster weight loss drug Ozempic in 2023, I groaned. Yes, weight loss drugs always generate feverish interest, but historically, they’ve both ...

New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...

Weight loss injections can help people lose more weight than with other methods of weight loss, including lifestyle changes ...

New research finds that men taking a GLP-1 for their obesity or type 2 diabetes often experience a rise in testosterone levels.

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Some online pharmacies sell semaglutide and tirzepatide that are ineffective, unsafe, or an outright scam. Here’s how to find ...

MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...

This lawsuit may look like a business dispute on the surface. But underneath, it’s about something much more important: the right of patients to receive personalized, affordable care.

5. It also outlined the eligibility and rationale for weight-loss medication as a treatment for obesity, including the use of newly approved drugs, including GLP-1 receptor agonists like semaglutide ...

Study comparing bariatric surgery to GLP-1 medications shows 24% total weight loss from surgery versus 4.7% from injectables, ...

New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and Ozempic for weight loss and lowering blood sugar.